688767 博拓生物
交易中 12-25 09:47:11
资讯
新帖
简况
12月11日博拓生物发布公告，股东减持84.33万股
证券之星 · 12-11
12月11日博拓生物发布公告，股东减持84.33万股
博拓生物（688767）披露2024年员工持股计划首次受让股份第一个锁定期届满暨解锁条件成就提示性公告，12月3日股价上涨2.44%
证券之星 · 12-03
博拓生物（688767）披露2024年员工持股计划首次受让股份第一个锁定期届满暨解锁条件成就提示性公告，12月3日股价上涨2.44%
每周股票复盘：11月19日博拓生物（688767）现6笔大宗交易
证券之星 · 11-23
每周股票复盘：11月19日博拓生物（688767）现6笔大宗交易
11月19日博拓生物现6笔大宗交易 机构净买入8635.02万元
证券之星 · 11-19
11月19日博拓生物现6笔大宗交易 机构净买入8635.02万元
每周股票复盘：博拓生物（688767）股东户数增28%至7146户
证券之星 · 11-02
每周股票复盘：博拓生物（688767）股东户数增28%至7146户
图解博拓生物三季报：第三季度单季净利润同比下降42.12%
证券之星 · 10-29
图解博拓生物三季报：第三季度单季净利润同比下降42.12%
每周股票复盘：博拓生物（688767）股东户数降10.13%，中报净利降82.82%
证券之星 · 08-31
每周股票复盘：博拓生物（688767）股东户数降10.13%，中报净利降82.82%
博拓生物（688767）2025年中报简析：净利润同比下降82.82%，三费占比上升明显
证券之星 · 08-30
博拓生物（688767）2025年中报简析：净利润同比下降82.82%，三费占比上升明显
股市必读：博拓生物中报 - 第二季度单季净利润同比下降88.72%
证券之星 · 08-29
股市必读：博拓生物中报 - 第二季度单季净利润同比下降88.72%
博拓生物(688767.SH)发布半年度业绩，归母净利润1240万元，同比下降82.82%
智通财经网 · 08-28
博拓生物(688767.SH)发布半年度业绩，归母净利润1240万元，同比下降82.82%
每周股票复盘：博拓生物（688767）实控人拟减持不超4,479,999股
证券之星 · 08-24
每周股票复盘：博拓生物（688767）实控人拟减持不超4,479,999股
博拓生物：于秀萍9月起拟减持3%股份
金融界 · 08-20
博拓生物：于秀萍9月起拟减持3%股份
博拓生物收盘下跌2.66%，滚动市盈率48.48倍，总市值67.20亿元
金融界 · 08-19
博拓生物收盘下跌2.66%，滚动市盈率48.48倍，总市值67.20亿元
8月14日博拓生物（688767）龙虎榜数据：机构净买入1587.34万元
证券之星 · 08-14
8月14日博拓生物（688767）龙虎榜数据：机构净买入1587.34万元
异动快报：博拓生物（688767）8月14日11点1分触及涨停板
证券之星 · 08-14
异动快报：博拓生物（688767）8月14日11点1分触及涨停板
博拓生物股价下跌5.62% 业绩下滑叠加资金流出压力
智选洞察 · 08-11
博拓生物股价下跌5.62% 业绩下滑叠加资金流出压力
医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道
国金证券 · 08-10
医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道
新冠检测概念盘中拉升，博拓生物涨11.64%
市场透视 · 08-08
新冠检测概念盘中拉升，博拓生物涨11.64%
猴痘概念盘中拉升，博拓生物涨9.89%
市场透视 · 08-08
猴痘概念盘中拉升，博拓生物涨9.89%
医药生物行业盘中拉升，赛诺医疗等3只股票涨停
市场透视 · 08-08
医药生物行业盘中拉升，赛诺医疗等3只股票涨停
加载更多
公司概况
公司名称：
杭州博拓生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2021-09-08
主营业务：
杭州博拓生物科技股份有限公司的主营业务是研发、生产和销售POCT诊断试剂产品。公司的主要产品是药物滥用（毒品）检测系列、传染病检测系列、生殖健康检测系列、肿瘤标志物检测系列、心肌标志物检测系列、抗原/抗体生物原料、动物疾病检测平台系列、炎症系列、分子诊断平台系列、其他。
发行价格：
34.55
{"stockData":{"symbol":"688767","market":"SH","secType":"STK","nameCN":"博拓生物","latestPrice":39.81,"timestamp":1766627231000,"preClose":39.89,"halted":0,"volume":733735,"delay":0,"changeRate":-0.002,"floatShares":149000000,"shares":149000000,"eps":0.6869,"marketStatus":"交易中","change":-0.08,"latestTime":"12-25 09:47:11","open":39.6,"high":40.3,"low":39.6,"amount":29393900,"amplitude":0.0175,"askPrice":40,"askSize":132,"bidPrice":39.86,"bidSize":38,"shortable":0,"etf":0,"ttmEps":0.6869,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1766633400000},"marketStatusCode":2,"adr":0,"adjPreClose":39.89,"symbolType":"stock_kcb","openAndCloseTimeList":[[1766626200000,1766633400000],[1766638800000,1766646000000]],"highLimit":43.88,"lowLimit":35.9,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":149333334,"isCdr":false,"pbRate":2.55,"roa":"--","peRate":57.956034,"roe":"0.94%","epsLYR":1.61,"committee":-0.085546,"marketValue":5945000000,"turnoverRate":0.0049,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-12-29。","floatMarketCap":5945000000},"requestUrl":"/m/hq/s/688767","defaultTab":"news","newsList":[{"id":"2590594491","title":"12月11日博拓生物发布公告，股东减持84.33万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590594491","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590594491?lang=zh_cn&edition=full","pubTime":"2025-12-11 18:03","pubTimestamp":1765447398,"startTime":"0","endTime":"0","summary":"证券之星消息，12月11日博拓生物发布公告《博拓生物:博拓生物实际控制人减持股份计划期间届满暨减持股份结果公告》，其股东于秀萍于2025年11月20日至2025年12月2日间合计减持84.33万股，占公司目前总股本的0.5647%，变动期间该股股价下跌8.88%，截止12月2日收盘报38.06元。股东增减持详情见下表：根据博拓生物2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100030007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2588042255","title":"博拓生物（688767）披露2024年员工持股计划首次受让股份第一个锁定期届满暨解锁条件成就提示性公告，12月3日股价上涨2.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588042255","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588042255?lang=zh_cn&edition=full","pubTime":"2025-12-03 22:34","pubTimestamp":1764772469,"startTime":"0","endTime":"0","summary":"截至2025年12月3日收盘，博拓生物报收于38.99元，较前一交易日上涨2.44%，最新总市值为58.23亿元。该股当日开盘38.49元，最高39.49元，最低37.71元，成交额达5690.71万元，换手率为0.99%。公司近日发布公告称，杭州博拓生物科技股份有限公司2024年员工持股计划首次受让股份第一个锁定期将于2025年12月5日届满，解锁条件已成就。管理委员会将按规定择机出售或过户已解锁股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300040558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2585989106","title":"每周股票复盘：11月19日博拓生物（688767）现6笔大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2585989106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585989106?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:42","pubTimestamp":1763844130,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，博拓生物报收于38.43元，较上周的41.7元下跌7.84%。本周，博拓生物11月19日盘中最高价报42.68元。博拓生物当前最新总市值57.39亿元，在医疗器械板块市值排名61/126，在两市A股市值排名2888/5167。本次权益变动后，于秀萍及其一致行动人合计持有公司股份比例由58.05%减少至55.61%，触及1%整数倍。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2584774914","title":"11月19日博拓生物现6笔大宗交易 机构净买入8635.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584774914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584774914?lang=zh_cn&edition=full","pubTime":"2025-11-19 17:34","pubTimestamp":1763544873,"startTime":"0","endTime":"0","summary":"证券之星消息，11月19日博拓生物发生大宗交易，交易数据如下：近三个月该股共发生6笔大宗交易，合计成交2.99万手，折价成交6笔。该股近期无解禁股上市。截至2025年11月19日收盘，博拓生物(688767)报收于41.77元，上涨0.77%，换手率0.87%，成交量1.3万手，成交额5487.98万元。该股最近90天内共有1家机构给出评级，增持评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900028240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2580405051","title":"每周股票复盘：博拓生物（688767）股东户数增28%至7146户","url":"https://stock-news.laohu8.com/highlight/detail?id=2580405051","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580405051?lang=zh_cn&edition=full","pubTime":"2025-11-02 10:45","pubTimestamp":1762051509,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，博拓生物报收于46.61元，较上周的44.76元上涨4.13%。本周，博拓生物10月30日盘中最高价报48.38元。博拓生物当前最新总市值69.6亿元，在医疗器械板块市值排名53/126，在两市A股市值排名2558/5163。本周关注点股本股东变化：截至2025年9月30日股东户数为7146户，较6月30日增加1563户，增幅28.0%。业绩披露要点博拓生物2025年三季报显示，前三季度公司主营收入3.08亿元，同比下降20.76%；归母净利润2226.32万元，同比下降75.04%；扣非净利润1509.57万元，同比下降81.4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2579565974","title":"图解博拓生物三季报：第三季度单季净利润同比下降42.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579565974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579565974?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:54","pubTimestamp":1761735273,"startTime":"0","endTime":"0","summary":"证券之星消息，博拓生物2025年三季报显示，前三季度公司主营收入3.08亿元，同比下降20.76%；归母净利润2226.32万元，同比下降75.04%；扣非净利润1509.57万元，同比下降81.4%；其中2025年第三季度，公司单季度主营收入1.05亿元，同比下降13.84%；单季度归母净利润986.09万元，同比下降42.12%；单季度扣非净利润826.09万元，同比下降25.2%；负债率5.44%，投资收益320.85万元，财务费用-1846.32万元，毛利率46.28%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900039621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767"],"gpt_icon":0},{"id":"2563839211","title":"每周股票复盘：博拓生物（688767）股东户数降10.13%，中报净利降82.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563839211","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563839211?lang=zh_cn&edition=full","pubTime":"2025-08-31 11:54","pubTimestamp":1756612450,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，博拓生物报收于39.2元，较上周的40.89元下跌4.13%。本周，博拓生物8月26日盘中最高价报43.2元。业绩披露要点：2025年中报归母净利润1240.24万元，同比下降82.82%。股本股东变化截至2025年6月30日，公司股东户数为5583户，较3月31日减少629户，减幅10.13%。2025年第二季度单季度主营收入1.15亿元，同比下降12.27%；单季度归母净利润366.99万元，同比下降88.72%；单季度扣非净利润46.03万元，同比下降98.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100003327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688767"],"gpt_icon":0},{"id":"2563527070","title":"博拓生物（688767）2025年中报简析：净利润同比下降82.82%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2563527070","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563527070?lang=zh_cn&edition=full","pubTime":"2025-08-30 06:19","pubTimestamp":1756505991,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期博拓生物发布2025年中报。截至本报告期末，公司营业总收入2.03亿元，同比下降23.91%，归母净利润1240.24万元，同比下降82.82%。本报告期博拓生物三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达488.84%。然而去年的净利率为29.81%，算上全部成本后，公司产品或服务的附加值高。持有博拓生物最多的基金为广发价值核心混合A，目前规模为35.16亿元，最新净值0.9792，较上一交易日上涨0.38%，近一年上涨112.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083000010740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767"],"gpt_icon":0},{"id":"2563066790","title":"股市必读：博拓生物中报 - 第二季度单季净利润同比下降88.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563066790","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563066790?lang=zh_cn&edition=full","pubTime":"2025-08-29 04:17","pubTimestamp":1756412231,"startTime":"0","endTime":"0","summary":"截至2025年8月28日收盘，博拓生物报收于39.8元，上涨2.18%，换手率2.98%，成交量4.45万手，成交额1.74亿元。股本股东变化股东户数变动近日博拓生物披露，截至2025年6月30日公司股东户数为5583.0户，较3月31日减少629.0户，减幅为10.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900004370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767"],"gpt_icon":0},{"id":"2562089911","title":"博拓生物(688767.SH)发布半年度业绩，归母净利润1240万元，同比下降82.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562089911","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562089911?lang=zh_cn&edition=full","pubTime":"2025-08-28 16:37","pubTimestamp":1756370236,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博拓生物(688767.SH)披露2025年半年度报告，报告期公司实现营收2.03亿元，同比下降23.91%;归母净利润1240万元，同比下降82.82%;扣非净利润683万元，同比下降90.25%;基本每股收益0.07元。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1337186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["688767"],"gpt_icon":0},{"id":"2561237481","title":"每周股票复盘：博拓生物（688767）实控人拟减持不超4,479,999股","url":"https://stock-news.laohu8.com/highlight/detail?id=2561237481","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561237481?lang=zh_cn&edition=full","pubTime":"2025-08-24 01:54","pubTimestamp":1755971653,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘，博拓生物报收于40.89元，较上周的44.35元下跌7.8%。本周，博拓生物8月18日盘中最高价报50.0元，股价触及近一年最高点。本周关注点公司公告汇总: 博拓生物实控人拟减持不超4,479,999股，即不超过公司股份总数的3%公司公告汇总博拓生物实际控制人于秀萍女士持有公司股份24,953,600股，占公司股份总数的16.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400000410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2560170390","title":"博拓生物：于秀萍9月起拟减持3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2560170390","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560170390?lang=zh_cn&edition=full","pubTime":"2025-08-20 19:11","pubTimestamp":1755688316,"startTime":"0","endTime":"0","summary":"博拓生物公告，截至本公告披露日，实际控制人于秀萍持有公司2495.36万股，占16.71%。其因自身资金需求，拟于2025年9月12日～2025年12月11日，通过集中竞价减持不超过149.33万股（1%）、大宗交易减持不超过298.67万股（2%），合计不超过448万股，即不超过3%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/20191152570955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2560973196","title":"博拓生物收盘下跌2.66%，滚动市盈率48.48倍，总市值67.20亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560973196","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560973196?lang=zh_cn&edition=full","pubTime":"2025-08-19 19:55","pubTimestamp":1755604530,"startTime":"0","endTime":"0","summary":"8月19日，博拓生物今日收盘45.0元，下跌2.66%，滚动市盈率PE达到48.48倍，总市值67.20亿元。从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均59.49倍，行业中值40.19倍，博拓生物排名第84位。截至2025年一季报，共有2家机构持仓博拓生物，其中基金2家，合计持股数425.46万股，持股市值1.52亿元。杭州博拓生物科技股份有限公司的主营业务是POCT诊断试剂的研发、生产和销售。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/19195552544042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2559953456","title":"8月14日博拓生物（688767）龙虎榜数据：机构净买入1587.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559953456","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559953456?lang=zh_cn&edition=full","pubTime":"2025-08-14 17:17","pubTimestamp":1755163069,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年8月14日公布的交易公开信息显示，博拓生物因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年8月14日收盘，博拓生物报收于45.13元，上涨19.99%，涨停，换手率6.99%，成交量10.43万手，成交额4.36亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入1587.34万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081400032269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688767"],"gpt_icon":0},{"id":"2559935470","title":"异动快报：博拓生物（688767）8月14日11点1分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2559935470","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559935470?lang=zh_cn&edition=full","pubTime":"2025-08-14 11:05","pubTimestamp":1755140727,"startTime":"0","endTime":"0","summary":"证券之星8月14日盘中消息，11点1分博拓生物（688767）触及涨停板。目前价格45.13，上涨19.99%。其所属行业医疗器械目前下跌。领涨股为博拓生物。该股为猴痘概念，体外诊断，医疗器械概念热股。8月13日的资金流向数据方面，主力资金净流出1022.08万元，占总成交额5.13%，游资资金净流入1238.31万元，占总成交额6.22%，散户资金净流出216.23万元，占总成交额1.09%。近5日资金流向一览见下表：博拓生物主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081400017132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2558365166","title":"博拓生物股价下跌5.62% 业绩下滑叠加资金流出压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2558365166","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558365166?lang=zh_cn&edition=full","pubTime":"2025-08-11 10:02","pubTimestamp":1754877760,"startTime":"0","endTime":"0","summary":"博拓生物股价大幅下跌，最新价34.45元/股，跌幅5.62%。资金博弈与基本面预期交织下的波动成因博拓生物近期股价波动受多重因素扰动。截至8月7日，近5个交易日主力资金累计净流出超1600万元，但8月7日突现171.1万元净流入，反映多空分歧加剧。2025年一季度营收同比下滑35.2%，叠加基孔肯雅热检测订单尚未兑现，业绩真空期加剧市场担忧。技术面支撑位与资金博弈形成拉锯，截至8月11日10时02分，股价振幅达6%印证短期情绪波动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811100337a480f316&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811100337a480f316&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2558835566","title":"医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道","url":"https://stock-news.laohu8.com/highlight/detail?id=2558835566","media":"国金证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558835566?lang=zh_cn&edition=full","pubTime":"2025-08-10 12:06","pubTimestamp":1754798792,"startTime":"0","endTime":"0","summary":"投资逻辑国内政策叠加资本双重支持，行业迎来重大发展机遇。近年来国内政策端对脑机接口行业支持力度较高，支持性政策在产品注册、医保支付、行业标准等层面均有体现。1）在产品注册方面，国家药监局将配合相关部门出台基于脑机接口技术的医疗器械产品支持政策，脑机接口相关产品有望通过创新器械绿色通道实现更快注册审批。其中医疗健康领域仍是脑机接口应用最大的细分领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600587","603658","688338","603880","688029","688301","688067","688273","688613","603205","688358","688075","688108","688151","688085","688198","688677","688314","603309","688580","600645","688755","688767","688426","688468","688656","688298","688139","688366","688114","600055","688617","600529","688289","605369","688068","688026","688050","603222","688575","688393","688271","560260","688236","688016","688576","688581","688410","603014","688317","688351","603987","688389","159883","600807","688253","688606","688607","688277","688193","603387","688013","688161","688217","603976","688212"],"gpt_icon":0},{"id":"2557516243","title":"新冠检测概念盘中拉升，博拓生物涨11.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557516243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557516243?lang=zh_cn&edition=full","pubTime":"2025-08-08 10:30","pubTimestamp":1754620258,"startTime":"0","endTime":"0","summary":"08月08日，新冠检测概念盘中拉升，截至10点30分，新冠检测概念整体指数上涨1.00%，报999.320点。从个股上来看，该概念的成分股中，博拓生物涨11.64%，乐普医疗、广生堂等3只股涨幅超过5%。从资金上来看，截止发稿，新冠检测概念主力净流入为-2616.39万，其中乐普医疗受到资金热捧，主力净流入1.30亿；拉长时间线来看，该板块近20日主力资金净流入-78.51亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808103058973ad7b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808103058973ad7b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2557162125","title":"猴痘概念盘中拉升，博拓生物涨9.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557162125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557162125?lang=zh_cn&edition=full","pubTime":"2025-08-08 10:23","pubTimestamp":1754619805,"startTime":"0","endTime":"0","summary":"08月08日，猴痘概念盘中拉升，截至10点23分，猴痘概念整体指数上涨1.02%，报1152.500点。从个股上来看，该概念的成分股中，博拓生物涨9.89%，乐普医疗、君实生物-U2只股涨幅超过5%。从资金上来看，截止发稿，猴痘概念主力净流入为-2.34亿，其中乐普医疗受到资金热捧，主力净流入1.36亿；拉长时间线来看，该板块近20日主力资金净流入-48.65亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808102325a6d9ec3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808102325a6d9ec3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688180","688767"],"gpt_icon":0},{"id":"2557590516","title":"医药生物行业盘中拉升，赛诺医疗等3只股票涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2557590516","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557590516?lang=zh_cn&edition=full","pubTime":"2025-08-08 10:15","pubTimestamp":1754619337,"startTime":"0","endTime":"0","summary":"08月08日，医药生物行业盘中拉升，截至10点15分，医药生物行业整体指数上涨0.50%，报8762.890点。从个股上来看，该行业的成分股中，创新医疗、麦澜德、三博脑科等4只个股涨幅超过10%，赛诺医疗等3只股票涨停，尚荣医疗、博拓生物等5只股涨幅超过5%。从资金上来看，截止发稿，医药生物行业主力净流入为-32.31亿，其中乐普医疗受到资金热捧，主力净流入1.39亿；拉长时间线来看，该板块近20日主力资金净流入-471.12亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808101537a6d9e8ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808101537a6d9e8ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0251","000808.SH","163118","688108","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766627249763,"stockEarnings":[{"period":"1week","weight":0.064},{"period":"1month","weight":0.027},{"period":"3month","weight":-0.0388},{"period":"6month","weight":0.2125},{"period":"1year","weight":0.7841},{"period":"ytd","weight":0.7549}],"compareEarnings":[{"period":"1week","weight":0.0183},{"period":"1month","weight":0.0272},{"period":"3month","weight":0.0227},{"period":"6month","weight":0.1509},{"period":"1year","weight":0.1613},{"period":"ytd","weight":0.1758}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州博拓生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7146人(较上一季度增加28.00%)","perCapita":"20897股","listingDate":"2021-09-08","address":"浙江省杭州市余杭区中泰街道富泰路17号","registeredCapital":"14933万元","survey":" 杭州博拓生物科技股份有限公司的主营业务是研发、生产和销售POCT诊断试剂产品。公司的主要产品是药物滥用（毒品）检测系列、传染病检测系列、生殖健康检测系列、肿瘤标志物检测系列、心肌标志物检测系列、抗原/抗体生物原料、动物疾病检测平台系列、炎症系列、分子诊断平台系列、其他。","listedPrice":34.55},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博拓生物(688767)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博拓生物(688767)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博拓生物,688767,博拓生物股票,博拓生物股票老虎,博拓生物股票老虎国际,博拓生物行情,博拓生物股票行情,博拓生物股价,博拓生物股市,博拓生物股票价格,博拓生物股票交易,博拓生物股票购买,博拓生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博拓生物(688767)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博拓生物(688767)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}